REM-1086 Prodrugs (Rel-MD)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameREM-1086 Prodrugs (Rel-MD)
Drug Alias NameREM-1256
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRel-MD Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRel-MD Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A